A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.

A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.

BACKGROUND: According to the "autovaccination hypothesis," reexposure to human immunodeficiency virus (HIV) during treatment interruptions may stimulate the HIV-specific immune response and lead to low viremia after withdrawal of highly active antiretroviral treatment (HAART). Many patien...

Full description

Bibliographic Details
Main Authors:	Fagard, C, Oxenius, A, Günthard, H, Garcia, F, Le Braz, M, Mestre, G, Battegay, M, Furrer, H, Vernazza, P, Bernasconi, E, Telenti, A, Weber, R, Leduc, D, Yerly, S, Price, D, Dawson, S, Klimkait, T, Perneger, T, McLean, A, Clotet, B, Gatell, J, Perrin, L, Plana, M, Phillips, R, Hirschel, B
Format:	Journal article
Language:	English
Published:	2003

Similar Items

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
by: Oxenius, A, et al.
Published: (2002)

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study.
by: Wolbers, M, et al.
Published: (2007)

Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3.
by: Plana, M, et al.
Published: (2004)

Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load.
by: Samuel Alizon, et al.
Published: (2010-09-01)

The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients.
by: Niko Beerenwinkel, et al.
Published: (2013-01-01)

Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.
by: Oxenius, A, et al.
Published: (2002)

CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
by: Wolbers, M, et al.
Published: (2007)

Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.
by: Rohrbach, J, et al.
Published: (2010)

Human immunodeficiency virus-specific T lymphocyte cell
by: Oxenius, A, et al.
Published: (2001)

Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study.
by: Glass, T, et al.
Published: (2006)

Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load.
by: Oxenius, A, et al.
Published: (2002)

Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS.
by: Scherer, A, et al.
Published: (2004)

Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance.
by: di Iulio, J, et al.
Published: (2011)

Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.
by: Joos, B, et al.
Published: (2005)

Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study
by: Martinetti Gladys, et al.
Published: (2011-01-01)

Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens.
by: Alexandra U Scherrer, et al.
Published: (2012-01-01)

Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study.
by: Wolbers, M, et al.
Published: (2008)

Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis
by: Teja Turk, et al.
Published: (2017-09-01)

Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients.
by: Alexandra U Scherrer, et al.
Published: (2012-01-01)

Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy.
by: Oxenius, A, et al.
Published: (2002)

Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study.
by: Fux, C, et al.
Published: (2007)

Distribution of functional HIV-specific CD8 T lymphocytes between blood and secondary lymphoid organs after 8-18 months of antiretroviral therapy in acutely infected patients.
by: Oxenius, A, et al.
Published: (2001)

Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-Infection
by: Elzi Luigia, et al.
Published: (2011-11-01)

Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load.
by: Oxenius, A, et al.
Published: (2001)

Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
by: Tracy R Glass, et al.
Published: (2012-01-01)

Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study.
by: Viktor von Wyl, et al.
Published: (2013-01-01)

Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression.
by: Frater, A, et al.
Published: (2007)

Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007.
by: Marie Ballif, et al.
Published: (2009-01-01)

Disentangling human tolerance and resistance against HIV.
by: Roland R Regoes, et al.
Published: (2014-09-01)

Structured Treatment Interruptions and Low Doses of IL-2 in Patients with Primary HIV Infection. Inflammatory, Virological and Immunological Outcomes.
by: Omar Sued, et al.
Published: (2015-01-01)

Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections
by: Barnes, E, et al.
Published: (2010)

Inferring epidemic contact structure from phylogenetic trees.
by: Gabriel E Leventhal, et al.
Published: (2012-01-01)

Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy
by: Gasser, O, et al.
Published: (2013)

Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART
by: Chenjie Wan, et al.
Published: (2020-11-01)

Safely interruptible agents
by: Orseau, L, et al.
Published: (2016)

TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals.
by: Angus, B, et al.
Published: (2008)

Human Interruption Management in Workplace Environments: An Overview
by: M. Alkahtani, et al.
Published: (2020-04-01)

Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy.
by: Gasser, O, et al.
Published: (2013)

REPRESENT: REPresentativeness of RESearch data obtained through the ‘General Informed ConsENT’
by: Cristina Bosmani, et al.
Published: (2023-02-01)

Combining Wake-Up-Back-to-Bed with Cognitive Induction Techniques: Does Earlier Sleep Interruption Reduce Lucid Dream Induction Rate?
by: Daniel Erlacher, et al.
Published: (2022-04-01)